These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 39227687)
1. KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway. Ma Y; Zhang Y; Jiang X; Guan J; Wang H; Zhang J; Tong Y; Qiu X; Zhou R Sci Rep; 2024 Sep; 14(1):20471. PubMed ID: 39227687 [TBL] [Abstract][Full Text] [Related]
2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
3. UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway. He L; Chen H; Ruan B; He L; Luo M; Fu Y; Zou R J Cancer Res Clin Oncol; 2024 Jul; 150(7):335. PubMed ID: 38969831 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
5. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway. Yang WB; Zhang WP; Shi JL; Wang JW Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192 [TBL] [Abstract][Full Text] [Related]
6. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway. Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844 [TBL] [Abstract][Full Text] [Related]
7. Eupafolin regulates non-small-cell lung cancer cell proliferation,migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway. Wang X; Huang M; Xie W; Ding Q; Wang T J Biosci; 2023; 48():. PubMed ID: 36695419 [TBL] [Abstract][Full Text] [Related]
8. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195 [TBL] [Abstract][Full Text] [Related]
9. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway. Gao BB; Wang SX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077 [TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway. Guo Z; Ye H; Zheng X; Yin W; He J J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116 [TBL] [Abstract][Full Text] [Related]
11. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer Liao H; Zhang L; Lu S; Li W; Dong W Front Genet; 2022; 13():848926. PubMed ID: 35812733 [No Abstract] [Full Text] [Related]
13. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression. Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225 [TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y; Song T; Shi Z; Li W; Yang S; Li D Gene; 2021 Feb; 768():145309. PubMed ID: 33197518 [TBL] [Abstract][Full Text] [Related]
15. KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway. Lu S; Liu Y; Tian S; He Y; Dong W Exp Cell Res; 2023 May; 426(1):113564. PubMed ID: 36948354 [TBL] [Abstract][Full Text] [Related]
16. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Xia H; Li Y; Lv X Int J Oncol; 2016 Oct; 49(4):1325-33. PubMed ID: 27498977 [TBL] [Abstract][Full Text] [Related]
18. Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway. Zhang HB; Qiu XM; Zhang YC; Huang TT; Zuo ZJ; Zhang T Bioengineered; 2022 Jan; 13(1):1590-1601. PubMed ID: 35000535 [TBL] [Abstract][Full Text] [Related]
19. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway. Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]